Lazzarotto D, Testi AM, Fanin M, Mosna F, et al. Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group. Ann Hematol 2025 Aug 27. doi: 10.1007/s00277-025-06550.
PMID: 40858769